©2024 Stanford Medicine
Stanford Letter or Traditional Advance Directive in Advance Care Planning in Patients Undergoing Bone Marrow Transplant
Not Recruiting
Trial ID: NCT03028961
Purpose
The purpose of the proposed research study is to evaluate whether bone marrow transplant
patients prefer the Stanford letter advance care planning tool to the standard Advance
directive.
Completion of advance care planning prior to BMT is very important, but not often done. The
investigators believe that the Stanford Letter will be preferred by patients and will allow
them to feel more comfortable and share more of their wishes with family members and the
medical team.
Official Title
Randomized Clinical Study Comparing the Effectiveness of the Stanford Letter to the Traditional Advance Directive in Bone Marrow Transplant Recipients
Stanford Investigator(s)
Lori Muffly
Associate Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
Eligibility
Inclusion Criteria:
- All BMT patients at Stanford who are adults and give consent
Exclusion Criteria:
- Less than 18 years of age
Intervention(s):
other: Stanford Letter
other: Interview
other: Questionnaire Administration
other: CA Advance Health Care Directive Form
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
VJ PERIYAKOIL, MD
650-493-5000